Rashid Sharaf, MD
Nephrology · San Antonio, TXNPI 1265471155
Payments from drug & device makers
Across 473 payments — averaging $1397.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$570K
- Lilly USA, LLC$40K
- Boehringer Ingelheim$32K
- Avenu Medical Inc.$10K
- Covidien LP$7K
- Venturemed Group, Inc.$285
- plus $1K from 12 others
What the payments were for
- Consulting fees$30,0509%
- Speaking & faculty fees$271,85080%
- Travel & lodging$23,4237%
- Food & beverage$14,9984%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 341 | $570,321 |
| Lilly USA, LLC | 38 | $39,972 |
| Boehringer Ingelheim | 46 | $31,607 |
| Avenu Medical Inc. | 4 | $10,263 |
| Covidien LP | 11 | $7,283 |
| Venturemed Group, Inc. | 3 | $285 |
| OPKO Pharmaceuticals, LLC | 2 | $270 |
| Novartis | 9 | $168 |
| GSK | 4 | $165 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Bard Peripheral Vascular, Inc. | 4 | $112 |
| Celonova Biosciences, Inc. | 1 | $81 |
| Mozarc Medical US LLC | 3 | $74 |
| Philips North America LLC | 2 | $33 |
| Boston Scientific | 1 | $19 |
| Nxstage Medical, Inc. | 1 | $19 |
| Cormedix Inc. | 1 | $18 |
| Biotronik Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELLIPSYS VASCULAR ACCESS SYSTEM$156,079
- Ellipsys$80,572
- JARDIANCE$66,472
- IN.PACT AV$14,765
- Argyle$7,200
- IN.PACT Admiral$2,859
- FLEX Vessel Prep System$260
- Rayaldee$180
- Abre$132
- TARPEYO$125
- BENLYSTA$121
How this compares
$660,828 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $191 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 45 | $181 |
| ClopidogrelClopidogrel Bisulfate | 47 | $158 |
| ConstuloseLactulose | 44 | $153 |
| Lactulose | 45 | $150 |
| Prednisone | 66 | $117 |
| Gabapentin | 12 | $58 |
| Cephalexin | 11 | $49 |
| EnuloseLactulose | 14 | $47 |
| Levofloxacin | 21 | $43 |
Paid to pharmacies, not to this prescriber.
Other nephrology in San Antonio
- Pablo PergolaSan Antonio$14.2M
- Tahira AlvesSan Antonio$6.1M
- Carl DukesSan Antonio$5.9M
- Chinonye Ogbonnaya-OdorSan Antonio$4.6M
- Wesley CalhounSan Antonio$3.5M
- Shweta BansalSan Antonio$1.7M
- Robert SzewcSan Antonio$1.5M
- Varshasb BroumandSan Antonio$538K
- Luis VelezSan Antonio$505K
- Steven GougeSan Antonio$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.